GE Healthcare Speeds Assay Development with Pre-Validated Conditions for GPCR Studies
GE Healthcare, a combination of the former Amersham and GE Medical Systems, is to help further address bottlenecks in the drug discovery process with the introduction of a range of pre-developed protocols for GPCR membranes. These pre-validated protocols offer substantial time-savings of up to 15 days during the GPCR assay development stage.
The new SPA GPCR Assays offer researchers working in high throughput screening environments pre-developed assay conditions for GPCR receptor-ligand binding studies.
“GE Healthcare is continually working to help cut development time throughout the drug discovery process,” comments John Sutton, vice president product management, cell analysis & screening at GE Healthcare. “This is the first time that SPA GPCR protocols have been available in this way. By providing ready-made optimum assay conditions for GPCR ligand binding studies, GE Healthcare is reducing assay development process time for researchers, therefore enabling them to focus on screening potential drug candidates.”
These SPA GPCR Assays broaden GE Healthcare’s SPA range and comprise SPA beads and radioligands from GE Healthcare with GPCR receptor membranes from Euroscreen S.A., as well as a pre-validated protocol describing the required procedure for the GPCR assay.
GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare’s expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals is dedicated to detecting disease earlier and tailoring treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer’s and cardiovascular diseases.
GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com
